Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2011 2
2012 1
2013 1
2014 4
2015 4
2016 3
2017 4
2018 4
2019 2
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.
Philippe M, Ranchon F, Gilis L, Schwiertz V, Vantard N, Ader F, Labussiere-Wallet H, Thomas X, Nicolini FE, Wattel E, Ducastelle-Leprêtre S, Barraco F, Lebras L, Salles G, Michallet M, Rioufol C. Philippe M, et al. Among authors: schwiertz v. Biol Blood Marrow Transplant. 2016 Apr;22(4):723-730. doi: 10.1016/j.bbmt.2015.12.009. Epub 2015 Dec 21. Biol Blood Marrow Transplant. 2016. PMID: 26718666 Free article.
Human-simulation-based learning to prevent medication error: A systematic review.
Sarfati L, Ranchon F, Vantard N, Schwiertz V, Larbre V, Parat S, Faudel A, Rioufol C. Sarfati L, et al. Among authors: schwiertz v. J Eval Clin Pract. 2019 Feb;25(1):11-20. doi: 10.1111/jep.12883. Epub 2018 Jan 31. J Eval Clin Pract. 2019. PMID: 29383867
Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?
Ranchon F, Vantard N, Henin E, Bachy E, Sarkozy C, Karlin L, Bouafia-Sauvy F, Gouraud A, Schwiertz V, Bourbon E, Baudouin A, Caffin AG, Vial T, Salles G, Rioufol C. Ranchon F, et al. Among authors: schwiertz v. Hematol Oncol. 2018 Apr;36(2):399-406. doi: 10.1002/hon.2479. Epub 2017 Oct 6. Hematol Oncol. 2018. PMID: 28983943
Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients.
Le Saux O, Bourmaud A, Rioufol C, Colomban O, Guitton J, Schwiertz V, Regnier V, You B, Ranchon F, Maraval-Gaget R, Girard P, Chauvin F, Freyer G, Tod M, Henin E, Trillet-Lenoir V. Le Saux O, et al. Among authors: schwiertz v. Cancer Chemother Pharmacol. 2018 Aug;82(2):319-327. doi: 10.1007/s00280-018-3612-x. Epub 2018 Jun 15. Cancer Chemother Pharmacol. 2018. PMID: 29948022
New treatments for cutaneous metastatic melanoma: MAPK pathway-targeted and immune based therapies.
Ranchon F, Boespflug A, Rioufol C, Schwiertz V, Thomas L, Dalle S. Ranchon F, et al. Among authors: schwiertz v. Anticancer Agents Med Chem. 2015;15(4):461-7. doi: 10.2174/1871520615666150101125028. Anticancer Agents Med Chem. 2015. PMID: 25553438 Review.
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center.
Sesques P, Ferrant E, Safar V, Wallet F, Tordo J, Dhomps A, Karlin L, Brisou G, Vercasson M, Hospital-Gustem C, Schwiertz V, Ranchon F, Rioufol C, Choquet M, Sujobert P, Ghergus D, Bouafia F, Golfier C, Lequeu H, Lazareth A, Novelli S, Devic P, Traverse Glehen A, Viel S, Venet F, Mialou V, Hequet O, Chauchet A, Arkam Y, Nicolas-Virelizier E, Peyrade F, Cavalieri D, Ader F, Ghesquières H, Salles G, Bachy E. Sesques P, et al. Among authors: schwiertz v. Am J Hematol. 2020 Aug 3. doi: 10.1002/ajh.25951. Online ahead of print. Am J Hematol. 2020. PMID: 32744738
What do adult outpatients included in clinical trials know about the investigational drugs being assessed: A cross-sectional study in France.
Fronteau C, Paré M, Benoit P, Tollec S, Hamon C, Schwiertz V, Maillard C, Cransac A, Volteau C, Huon JF, Burgeot V, Tching-Sin M, Guérin C, Flet L. Fronteau C, et al. Among authors: schwiertz v. PLoS One. 2019 Aug 13;14(8):e0220383. doi: 10.1371/journal.pone.0220383. eCollection 2019. PLoS One. 2019. PMID: 31408456 Free PMC article.
[Evolution of reimbursement of high-cost anticancer drugs: Financial impact within a university hospital].
Baudouin A, Fargier E, Cerruti A, Dubromel A, Vantard N, Ranchon F, Schwiertz V, Salles G, Souquet PJ, Thomas L, Bérard F, Nancey S, Freyer G, Trillet-Lenoir V, Rioufol C. Baudouin A, et al. Among authors: schwiertz v. Bull Cancer. 2017 Jun;104(6):538-551. doi: 10.1016/j.bulcan.2017.01.006. Epub 2017 Feb 23. Bull Cancer. 2017. PMID: 28237353 French.
EPICC study: evaluation of pharmaceutical intervention in cancer care.
Vantard N, Ranchon F, Schwiertz V, Gourc C, Gauthier N, Guedat MG, He S, Kiouris E, Alloux C, You B, Souquet PJ, Freyer G, Salles G, Trillet-Lenoir V, Rioufol C. Vantard N, et al. Among authors: schwiertz v. J Clin Pharm Ther. 2015 Apr;40(2):196-203. doi: 10.1111/jcpt.12242. Epub 2015 Jan 16. J Clin Pharm Ther. 2015. PMID: 25594148
Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients.
Tixier F, Ranchon F, Iltis A, Vantard N, Schwiertz V, Bachy E, Bouafia-Sauvy F, Sarkozy C, Tournamille JF, Gyan E, Salles G, Rioufol C. Tixier F, et al. Among authors: schwiertz v. Hematol Oncol. 2017 Dec;35(4):584-590. doi: 10.1002/hon.2328. Epub 2016 Jul 5. Hematol Oncol. 2017. PMID: 27377614
22 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback